The present results suggest that antagonists of the 5-HT 5A receptor may inhibit subjective effects of LSD in rats.

In animals trained to discriminate 0.08 mg/kg LSD from vehicle 15 minutes after injection, LSD produced dose-related increases in response, with an ED50 (±95% confidence limits) of 0.0384 (± 0.025–0.051) mg/kg). LSD-like responses were observed when the training dose of LSD was given 5–30 but not 90 minutes before the test. Confirming earlier reports, the 5-HT antagonist ketanserin (2 mg/kg) attenuated the LSD response in 50% of rats, and due to pretreatment with 0.2 and 2 mg/kg MDL 100907, 63% and 67% of animals, respectively, failed to select the LSD lever. We then investigated the effects of two 5-HT 5A receptor antagonists, and we found that 56% and 60% of rats pretreated with 3 and 10 mg/kg SB 699551, respectively, failed to select the LSD lever. Due to pretreatment with 0.01 mg/kg ASP 5736, 58% of rats did not select the LSD lever. This dose also reduced the response rate but not the number of rats failing to complete the test.

Using male Sprague Dawley rats, we examined the effects of 5-HT 2A and 5-HT 5A receptor antagonists on LSD-induced stimulus control in the two-lever drug discrimination test using a FR10 schedule of reinforcement.

Like other psychedelics, D-lysergic acid diethylamide (LSD) affects numerous serotonin receptors, and according to the current dogma, the 5-HT 2A receptors are considered the main target for its hallucinogenic effects. LSD, however, also displays agonistic activity at the 5-HT 5A receptors, which mediate some of LSD-induced behavioural effects.

References

Appel, JB, West, WB, Buggy, J ( 2004 ) LSD, 5-HT (serotonin), and the evolution of a behavioral assay . Neurosci Biobehav Rev 27: 693 – 701 .

Google Scholar Crossref | Medline

Arnt, J ( 1989 ) Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats . Pharmacol Toxicol 64: 165 – 172 .

Google Scholar Crossref | Medline

Baker, LE ( 2018 ) Hallucinogens in drug discrimination . Curr Top Behav Neurosci 36: 201 – 219 .

Google Scholar Crossref | Medline

Baker, MS, Ahn, SB, Mohamedali, A, et al . ( 2017 ) Accelerating the search for the missing proteins in the human proteome . Nat Commun 8: 14271 .

Google Scholar Crossref | Medline

Birkett, JT, Arranz, MJ, Munro, J, et al . ( 2000 ) Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response . Neuroreport 11: 2017 – 2020 .

Google Scholar Crossref | Medline | ISI

Bowers, MB, Freedman, DX ( 1966 ) ‘Psychedelic’ experiences in acute psychoses . Arch Gen Psychiatry 15: 240 – 248 .

Google Scholar Crossref | Medline

Callahan, PM, Appel, JB ( 1990 ) Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure . Psychopharmacology (Berl) 100: 13 – 18 .

Google Scholar Crossref | Medline

Colpaert, FC ( 1987 ) Drug discrimination: methods of manipulation, measurement, and analysis . In: Bozarth, MA (ed) Methods of Assessing the Reinforcing Properties of Abused Drugs. New York : Springer , pp. 341 – 372 .

Google Scholar Crossref

Colpaert, FC ( 1991 ) The discriminative response: an elementary particle of behavior Commentary on Stolerman ‘Measures of stimulus generalization in drug discrimination experiments’ . Behav Pharmacol 2: 283 – 286 .

Google Scholar Crossref | Medline

Colpaert, FC ( 2003 ) Discovering risperidone: the LSD model of psychopathology . Nat Rev Drug Discov 2: 315 – 320 .

Google Scholar Crossref | Medline | ISI

Colpaert, FC, Janssen, PA ( 1983 ) A characterization of LSD-antagonist effects of pirenperone in the rat . Neuropharmacology 22: 1001 – 1005 .

Google Scholar Crossref | Medline

Colpaert, FC, Niemegeers, CJ, Janssen, PA ( 1982 ) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist . J Pharmacol Exp Ther 221: 206 – 214 .

Google Scholar Medline

Corbett, DF, Heightman, TD, Moss, SF, et al . ( 2005 ) Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry . Bioorg Med Chem Lett 15: 4014 – 4018 .

Google Scholar Crossref | Medline

Cunningham, KA, Appel, JB ( 1987 ) Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD) . Psychopharmacology 91: 67 – 73 .

Google Scholar Crossref | Medline

Curtin, PC, Medan, V, Neumeister, H, et al . ( 2013 ) The 5-HT5A receptor regulates excitability in the auditory startle circuit: functional implications for sensorimotor gating . J Neurosci 33: 10011 – 10020 .

Google Scholar Crossref | Medline

Dubertret, C, Hanoun, N, Ades, J, et al . ( 2004 ) Family-based association studies between 5-HT5A receptor gene and schizophrenia . J Psychiatr Res 38: 371 – 376 .

Google Scholar Crossref | Medline

Egan, CT, Herrick-Davis, K, Miller, K, et al . ( 1998 ) Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors . Psychopharmacology (Berl) 136: 409 – 414 .

Google Scholar Crossref | Medline | ISI

Erlander, MG, Lovenberg, TW, Baron, BM, et al . ( 1993 ) Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain . Proc Natl Acad Sci U S A 90: 3452 – 3456 .

Google Scholar Crossref | Medline

Extance, K, Goudie, AJ ( 1981 ) Inter-animal olfactory cues in operant drug discrimination procedures in rats . Psychopharmacology 73: 363 – 371 .

Google Scholar Crossref | Medline

Field, A ( 2009 ) Discovering Statistics Using IBM SPSS. London : SAGE .

Google Scholar

Fiorella, D, Rabin, RA, Winter, JC ( 1995 a) Role of 5-HT2a and 5-HT2c receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives . Psychopharmacology 121: 357 – 363 .

Google Scholar Crossref | Medline

Fiorella, D, Rabin, RA, Winter, JC ( 1995 b) The role of the 5-HT2a and 5-HT2c receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis . Psychopharmacology 121: 347 – 356 .

Google Scholar Crossref | Medline

Fischman, LG ( 1983 ) Dreams, hallucinogenic drug states, and schizophrenia: a psychological and biological comparison . Schizophr Bull 9: 73 – 94 .

Google Scholar Crossref | Medline | ISI

Francken, BJ, Josson, K, Lijnen, P, et al . ( 2000 ) Human 5-hydroxytryptamine(5A) receptors activate coexpressed G(i) and G(o) proteins in Spodoptera frugiperda 9 cells . Mol Pharmacol 57: 1034 – 1044 .

Google Scholar Medline

Francken, BJ, Jurzak, M, Vanhauwe, JF, et al . ( 1998 ) The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells . Eur J Pharmacol 361: 299 – 309 .

Google Scholar Crossref | Medline

Freedman, DX ( 1986 ) Hallucinogenic drug research – if so, so what? Symposium summary and commentary . Pharmacol Biochem Behav 24: 407 – 415 .

Google Scholar Crossref | Medline

Glennon, RA, Titeler, M, McKenney, JD ( 1984 ) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents . Life Sci 35: 2505 – 2511 .

Google Scholar Crossref | Medline | ISI

Glennon, RA, Young, R, Rosecrans, JA ( 1983 ) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists . Eur J Pharmacol 91: 189 – 196 .

Google Scholar Crossref | Medline | ISI

González-Maeso, J, Weisstaub, NV, Zhou, M, et al . ( 2007 ) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior . Neuron 53: 439 – 452 .

Google Scholar Crossref | Medline | ISI

Gonzalez, R, Chavez-Pascacio, K, Meneses, A ( 2013 ) Role of 5-HT5A receptors in the consolidation of memory . Behav Brain Res 252: 246 – 251 .

Google Scholar Crossref | Medline

Goodfellow, NM, Bailey, CD, Lambe, EK ( 2012 ) The native serotonin 5-HT5A receptor: electrophysiological characterization in rodent cortex and 5-HT1A-mediated compensatory plasticity in the knock-out mouse . J Neurosci 32: 5804 – 5809 .

Google Scholar Crossref | Medline

Grailhe, R, Grabtree, GW, Hen, R ( 2001 ) Human 5-HT5 receptors: the 5-HT5A receptor is functional but the 5-HT5B receptor was lost during mammalian evolution . Eur J Pharmacol 418: 157 – 167 .

Google Scholar Crossref | Medline

Grailhe, R, Waeber, C, Dulawa, SC, et al . ( 1999 ) Increased exploratory activity and altered response to LSD in mice lacking the 5-HT5a receptor . Neuron 22: 581 – 591 .

Google Scholar Crossref | Medline

Gresch, PJ, Barrett, RJ, Sanders-Bush, E, et al . ( 2007 ) 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide . J Pharmacol Exp Ther 320: 662 – 669 .

Google Scholar Crossref | Medline

Halberstadt, AL, Geyer, MA ( 2013 ) Serotonergic hallucinogens as translational models relevant to schizophrenia . Int J Neuropsychopharmacol 16: 2165 – 2180 .

Google Scholar Crossref | Medline | ISI

Hoyer, D, Hannon, JP, Martin, GR ( 2002 ) Molecular, pharmacological and functional diversity of 5-HT receptors . Pharmacol Biochem Behav 71: 533 – 554 .

Google Scholar Crossref | Medline | ISI

Jongen-Relo, AL, Bespalov, AY, Rueter, LE, et al . ( 2006 ) Behavioral pharmacological characterization of 5-HT5A receptor antagonists in antipsychotic drug tests . In: 36th Annual Meeting of the Society for Neuroscience Meeting , Atlanta, GA, USA , . Abstract 529.26.

Google Scholar

Kassai, F, Schlumberger, C, Kedves, R, et al . ( 2012 ) Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression . Behav Pharmacol 23: 397 – 406 .

Google Scholar Crossref | Medline

Kyzar, EJ, Nichols, CD, Gainetdinov, RR, et al . ( 2017 ) Psychedelic drugs in biomedicine . Trends Pharmacol Sci 38: 992 – 1005 .

Google Scholar Crossref | Medline

Langs, RJ, Barr, HL ( 1968 ) Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study . J Nerv Ment Dis 147: 163 – 172 .

Google Scholar Crossref | Medline

Litchfield, JT, Wilcoxon, F ( 1949 ) A simplified method of a evaluating dose–effects experiments . J Pharmacol Exp Ther 96: 99 – 133 .

Google Scholar Medline | ISI

Marona-Lewicka, D, Nichols, DE ( 2007 ) Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action . Pharmacol Biochem Behav 87: 453 – 461 .

Google Scholar Crossref | Medline

Marona-Lewicka, D, Nichols, CD, Nichols, DE ( 2011 ) An animal model of schizophrenia based on chronic LSD administration: old idea, new results . Neuropharmacology 61: 503 – 512 .

Google Scholar Crossref | Medline | ISI

Marona-Lewicka, D, Thisted, RA, Nichols, DE ( 2005 ) Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis . Psychopharmacology (Berl) 180: 427 – 435 .

Google Scholar Crossref | Medline

Nelson, DL ( 2004 ) 5-HT5 receptors . Curr Drug Targets CNS Neurol Disord 3: 53 – 58 .

Google Scholar Crossref | Medline

Nichols, DE, Frescas, S, Marona-Lewicka, D, et al . ( 2002 ) Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD) . J Med Chem 45: 4344 – 4349 .

Google Scholar Crossref | Medline

Nikiforuk, A ( 2016 ) Serotonergic and cholinergic strategies as potential targets for the treatment of schizophrenia . Curr Pharm Des 22: 2093 – 2116 .

Google Scholar Crossref | Medline

Nikiforuk, A, Holuj, M, Kos, T, et al . ( 2016 ) The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia . Neuropharmacology 105: 351 – 360 .

Google Scholar Crossref | Medline

Pasqualetti, M, Ori, M, Nardi, I, et al . ( 1998 ) Distribution of the 5-HT5A serotonin receptor mRNA in the human brain . Brain Res Mol Brain Res 56: 1 – 8 .

Google Scholar Crossref | Medline

Plassat, JL, Boschert, U, Amlaiky, N, et al . ( 1992 ) The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family . EMBO J 11: 4779 – 4786 .

Google Scholar Crossref | Medline

Porter, JH, Prus, AJ, Overton, DA ( 2018 ) Drug discrimination: Historical origins, important concepts, and principles . In: Porter, JH, Prus, AJ (eds) The Behavioral Neuroscience of Drug Discrimination. Cham, Switzerland : Springer , pp. 3 – 26 .

Google Scholar Crossref

Preller, KH, Herdener, M, Pokorny, T, et al . ( 2017 ) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation . Curr Biol 27: 451 – 457 .

Google Scholar Crossref | Medline

Rees, S, den Daas, I, Foord, S, et al . ( 1994 ) Cloning and characterisation of the human 5-HT5A serotonin receptor . FEBS Lett 355: 242 – 246 .

Google Scholar Crossref | Medline

Reissig, CJ, Eckler, JR, Rabin, RA, et al . ( 2005 ) The 5-HT1A receptor and the stimulus effects of LSD in the rat . Psychopharmacology 182: 197 – 204 .

Google Scholar Crossref | Medline

Schreiber, R, Brocco, M, Millan, MJ ( 1994 ) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’ antipsychotics, clozapine and risperidone . Eur J Pharmacol 264: 99 – 102 .

Google Scholar Crossref | Medline

Schuster, CR, Johanson, CE ( 1988 ) Relationship between the discriminative stimulus properties and subjective effects of drugs . Psychopharmacol Ser 4: 161 – 175 .

Google Scholar Medline

Smith, RL, Canton, H, Barrett, RJ, et al . ( 1998 ) Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors . Pharmacol Biochem Behav 61: 323 – 330 .

Google Scholar Crossref | Medline | ISI

Solinas, M, Panlilio, LV, Justinova, Z, et al . ( 2006 ) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats . Nat Protoc 1: 1194 – 1206 .

Google Scholar Crossref | Medline

Stolerman, I ( 1991 ) Measures of stimulus generalization in drug discrimination experiments . Behav Pharmacol 2: 265 – 282 .

Google Scholar Crossref | Medline

Tallarida, RJ, Murray, RB ( 1987 ) Manual of Pharmacologic Calculations. New York : Springer .

Google Scholar

Thomas, DR ( 2006 ) 5-ht5A receptors as a therapeutic target . Pharmacol Ther 111: 707 – 714 .

Google Scholar Crossref | Medline | ISI

Volk, B, Nagy, BJ, Vas, S, et al . ( 2010 ) Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential . Curr Top Med Chem 10: 554 – 578 .

Google Scholar Crossref | Medline

Vollenweider, FX ( 1998 ) Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research . Pharmacopsychiatry 31: 92 – 103 .

Google Scholar Crossref | Medline

Wacker, D, Wang, S, McCorvy, JD, et al . ( 2017 ) Crystal structure of an LSD-bound human serotonin receptor . Cell 168: 377–389.e312.

Google Scholar Crossref | Medline

White, FJ, Appel, JB ( 1982 ) Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions . Science 216: 535 – 537 .

Google Scholar Crossref | Medline

Winter, JC, Eckler, JR, Rabin, RA ( 2004 ) Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli . Psychopharmacology (Berl) 172: 233 – 240 .

Google Scholar Crossref | Medline

Winter, JC, Rice, KC, Amorosi, DJ, et al . ( 2007 ) Psilocybin-induced stimulus control in the rat . Pharmacol Biochem Behav 87: 472 – 480 .

Google Scholar Crossref | Medline | ISI

Yamazaki, M, Harada, K, Yamamoto, N, et al . ( 2014 ) ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia . Eur Neuropsychopharmacol 24: 1698 – 1708 .

Google Scholar Crossref | Medline

Yamazaki, M, Okabe, M, Yamamoto, N, et al . ( 2015 ) Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats . J Pharmacol Sci 127: 362 – 369 .

Google Scholar Crossref | Medline